vimarsana.com

Page 25 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researcher Under FBI Investigation for Allegedly Hiding Ties to China

Researcher Under FBI Investigation for Allegedly Hiding Ties to China A Chinese researcher who once worked at The Jackson Laboratory is under FBI investigation, for allegedly failing to disclose his financial ties to China in applications for U.S. government funding. Ruan Yijun, a geneticist, failed to disclose his participation in a Chinese state-sponsored recruitment program called the Thousand Talents program and his collaboration agreement with China’s state-run Shenzhen People’s Hospital, according to an FBI affidavit unsealed on Mar. 2. The affidavit was filed in federal court in Bangor, Maine, on Dec. 30 last year. The Jackson Laboratory (JAX) is a nonprofit biomedical research institution based in Maine. Its mission is to discover genetic solutions for treating human diseases. According to Ruan’s curriculum vitae (pdf) available on the JAX website, he began working at JAX’s genomics research center at the campus of the University of Connecticut Health Center in 20

InnoCare Appoints Dr Sean Zhang as Chief Medical Officer

InnoCare Appoints Dr. Sean Zhang as Chief Medical Officer Search jobs InnoCare Appoints Dr. Sean Zhang as Chief Medical Officer BEIJING (BUSINESS WIRE) InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the Company appointed Dr. Sean Zhang as Chief Medical Officer (CMO). Reporting to the Co-founder, Chairwoman and CEO, Dr. Jasmine Cui. Dr. Zhang will be responsible for global clinical development strategy and execution for InnoCare. Dr. Zhang is based in U.S., thus demonstrating InnoCare’s ongoing commitment to globalization. As a physician scientist, Dr. Zhang has more than 30 years working experience in clinical practice, academic research and drug discovery and development. Before joining InnoCare, Dr. Zhang served as CMO and Member of the Board of Directors of Hengrui Therapeutics Inc. (HTI) before his promotion to CEO. HTI is a joint venture between Jiangsu Hengrui Me

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.